Sign In
Last checked at 
16 Sep 2021 14:14
The following amendments have been made to the 'Director/PDMR Shareholding' announcement released on 16/09/2021 at 12:47 p.m. under RNS No 0420M.
The price paid was 1.35 pence, not 0.0135 pence.
All other details remain unchanged.
16 September 2021
Nuformix plc
("Nuformix" or the "the Company")
Director/PDMR Shareholding
Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, announces that today the Company received notice that Dr Alastair Riddell purchased 350,000 ordinary shares of 0.1 pence each ("Ordinary Shares") at a price of 1.35 pence per share on 16 September 2021.
- Ends -
Enquiries:
Nuformix plc | +44 (0) 1223 627 222 |
Dr Anne Brindley, CEO | |
Allenby Capital Limited | +44 (0) 20 3328 5656 |
Nick Athanas / George Payne (Corporate Finance) | |
Stefano Aquilino / Matt Butlin (Sales & Corporate Broking) | |
Walbrook PR Anna Dunphy / Paul McManus | +44 (0) 20 7933 8780nuformix@walbrookpr.com |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Dr Alastair Riddell | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| PDMR - Chairman | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Nuformix plc | ||||
b)
| LEI
| 2138003XG3H3I2J3BJ24 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary Shares of nominal value 0.1 pence each
GB00BYW79Y38 | ||||
b)
| Nature of the transaction
| Purchase of Ordinary Shares | ||||
c)
| Price(s) and volume(s)
|
| ||||
d)
| Aggregated information
- Aggregated volume
- Price
- Total |
350,000
1.35p
£4,725.00 | ||||
e)
| Date of the transaction
| 16 September 2021 | ||||
f)
| Place of the transaction
| London Stock Exchange, Main Market | ||||
Follow the stocks
